Literature DB >> 17623534

Is ovarian stimulation detrimental to the endometrium?

José A Martínez-Conejero1, Carlos Simón, Antonio Pellicer, José A Horcajadas.   

Abstract

Ovarian stimulation in assisted reproduction technology produces lower implantation rates per embryo transferred than natural and ovum donation cycles, suggesting suboptimal endometrial development due to the abnormal concentrations of hormones used to recruit more oocytes. After the publication of several studies on the gene expression profile of endometrial receptivity in the natural cycle using microarray technology, researchers have investigated the impact of ovarian stimulation on the gene expression pattern of the endometrium. Ovarian stimulation cycles that use gonadotrophin-releasing hormone (GnRH) agonists and antagonists have been analysed in detail during the window of implantation to establish differences compared with the natural cycle. This paper reviews results obtained in different studies to elucidate the changes induced by the different protocols used in clinics. At the morphological level, no relevant alteration was observed in endometrial development in the early and mid-luteal phases in women undergoing ovarian stimulation following GnRH antagonist treatments. However, the gene expression pattern of the endometrium showed some differences. In addition, the endometrial development after GnRH antagonist mimics the natural endometrium more closely than after GnRH agonist at both the morphological (no relevant differences) and molecular level (only 23 genes dysregulated at high dose). Clinical implications of these differences should be analysed in more detail.

Entities:  

Mesh:

Year:  2007        PMID: 17623534     DOI: 10.1016/s1472-6483(10)60690-6

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  14 in total

1.  Different ART outcomes at increasing peak estradiol levels with long and antagonist protocols: retrospective insights from ten years experience.

Authors:  Massimo Manno; Marta Cervi; Donatella Zadro; Giuseppa Fuggetta; Valter Adamo; Francesco Tomei
Journal:  J Assist Reprod Genet       Date:  2011-04-26       Impact factor: 3.412

2.  Mild IVF using GnRH agonist long protocol is possible: comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose.

Authors:  Sylvia Fernández-Shaw; Nuria Pérez Esturo; Rosa Cercas Duque; Isabel Pons Mallol
Journal:  J Assist Reprod Genet       Date:  2009-01-17       Impact factor: 3.412

Review 3.  Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium.

Authors:  Signe Altmäe; Francisco J Esteban; Anneli Stavreus-Evers; Carlos Simón; Linda Giudice; Bruce A Lessey; Jose A Horcajadas; Nick S Macklon; Thomas D'Hooghe; Cristina Campoy; Bart C Fauser; Lois A Salamonsen; Andres Salumets
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

4.  Outcome Analysis of Day-3 Frozen Embryo Transfer v/s Fresh Embryo Transfer in Infertility: A Prospective Therapeutic Study in Indian Scenario.

Authors:  Neha Palo Chandel; Vidya V Bhat; B S Bhat; Sidharth S Chandel
Journal:  J Obstet Gynaecol India       Date:  2015-05-22

5.  Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.

Authors:  Qiaohong Lai; Hanwang Zhang; Guijing Zhu; Yufeng Li; Lei Jin; Long He; Zhijun Zhang; Ping Yang; Qilin Yu; Shu Zhang; Jun-Fa Xu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study.

Authors:  Bülent Berker; Candan İltemir Duvan; Cemil Kaya; Ruşen Aytaç; Hakan Satıroğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-12-01

7.  GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology.

Authors:  Ana Marcia M Cota; Joao Batista A Oliveira; Claudia G Petersen; Ana L Mauri; Fabiana C Massaro; Liliane F I Silva; Andreia Nicoletti; Mario Cavagna; Ricardo L R Baruffi; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-04-27       Impact factor: 5.211

Review 8.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

9.  Effects of "Bu Shen Huo Xue Decoction" on the Endometrial Morphology and Expression of Leukaemia Inhibitory Factor in the Rat Uterus during the Oestrous Cycle.

Authors:  Xin Gong; Yanyan Yu; Qing Tong; Ying Ren; Zhe Jin
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-28       Impact factor: 2.629

10.  A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation.

Authors:  Joao Batista A Oliveira; Ricardo L R Baruffi; Claudia G Petersen; Ana L Mauri; Adriana M Nascimento; Laura Vagnini; Juliana Ricci; Mario Cavagna; Jose G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-11-21       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.